NantHealth, maker of a cloud-based clinical platform, has raised an additional $250 million in Series B funding, bringing the funding round to a total of $320 million.
The NantHealth platform helps providers use big data to make decisions at the point of care. The platform pulls from patient genomic and proteomic data, scientific literature, clinical trial data and other sources to provide actionable information.
"Providers using NantHealth solutions have the ability to analyze an individual's unique genomic signature and collaborate and share data in real-time with all members of the patient’s healthcare team," said Laura Beggrow, executive vice president of commercialization at NantHealth. "This unique model has the potential to improve treatment decisions, as well as patient and financial outcomes, and that is groundbreaking."
In addition to the funding, NantHealth has expanded its leadership team to include former executives from WebMD, Genomics Health and KLAS.
More articles on the health IT market:
2014 will be another record-breaking year for digital health funding
UnitedHealth's IT division to acquire MedSynergies
Tenet IT subsidiary Conifer Health Solutions to acquire SPi Healthcare